Biocon settles Roche's US patent lawsuit over proposed breast — cancer drug copy
By Blake Brittain Oct 14 (Reuters) — Roche's Genentech has settled a US lawsuit against Indian biopharmaceutical company Biocon over its proposed biosimilar of Genentech's blockbuster breast-cancer drug Perjeta, Biocon said Wednesday. Biocon said in a statement that the settlement gives it the "earliest licensed launch